Latest Kaiser Health News Stories
Under the Trump administration’s new rule, these plans can now last as long as 12 months — instead of the Obama-era 90-day limit — and be renewed for two additional years. Critics say these changes are part of another swipe at the Affordable Care Act.
The administration says these plans, which can now last as long as 12 months and be renewed for two years, will give consumers another less-pricey insurance option. Critics say the new rule is yet another swipe at the Affordable Care Act.
The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.
The Trump administration says its plan to overhaul the way Medicare pays doctors will save physicians time and paperwork. But critics worry the changes will hurt patients’ care and doctors’ income.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
After a San Francisco speech focused mostly on Medicare, Seema Verma fielded questions that underscored the administration’s differences with California on other key health care issues.
Several major drugmakers vow to contain drug prices, but similar pledges since the 1990s have not had much impact.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of Stat News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.
At least 70 infants have been ordered to appear in immigration court. Experts believe some were separated from their parents.
As new federal policies make it harder to gain asylum in the U.S., foreign applicants try to improve their chances by having doctors evaluate their conditions — perhaps bolstering their stories of torture and violent persecution back home.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administration’s efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
Advocates of the sweeping health law view this move by the Trump administration as its most recent act of sabotage. But not everyone views it as a mortal blow.
The Trump administration suspended a program over the weekend that helps stabilize the health insurance exchanges created by the Affordable Care Act, prompting some insurance companies to warn of higher premiums. KHN’s Julie Rovner and Chad Terhune explain the uncertain health care landscape in the U.S.
Senate Democrats see health care as an issue that could keep their caucus unified as the confirmation battle heats up.